Skip to content

Testing the benefits of Finger Millet (Ragi) and Flax Seeds(Atsi) for Women going through Perimenopause

A randomized open labelled controlled Clinical study to evaluate the efficacy of Finger Millet (Ragi) and Flax Seeds (Atsi) in the Management of Perimenopausal Syndrome - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080197
Enrollment
40
Registered
2025-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N958- Other specified menopausal and perimenopausal disorders

Interventions

None listed

Sponsors

Institute For Ayurved Studies and Research Shri Krishna Ayush University Kurukshetra Haryana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having age 35 to 55 years. 2.Patients who are having symptoms of perimenopausal syndrome. 3.Patient who are willing to participate in the trial. 4.Patient who is having osteopenic changes.

Exclusion criteria

Exclusion criteria: 1.Known case of carcinoma. 2.Surgical history of menopause i.e.hysterectomy 3.Patient is having mental illness. 4.Patient having diabetes mellitus. 5.Patient is having uncontrolled hypertension,kidney disorder. 6.Patient on prolonged ( >6 weeks medication on corticosteroids ,antidepressant, anticholenrgics or any hormone replacement therapy or any other drug therapy that may have any influence on the outcome of study. 7.Patient having history of smoking,alcoholics and drug abusing. 8.Patient having any respiratory issues like asthma,COPD etc. 9.Patient who are not willing to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Improvement in the subjective parameters of Perimenopausal syndrome like hot flushes, fatigue,pain in joints etcTimepoint: follow up for the subjective parameters 1st month, 2nd month, 3rd month and two months after the trial. Telephonically once a week.

Secondary

MeasureTime frame
Quality of life of patient will be improved. Improvent in the symptoms of Perimenopausal symptoms.Timepoint: follow up for the subjective parameters 1st month, 2nd month, 3rd month and two months after the trial. Telephonically once a week.

Countries

India

Contacts

Public ContactDr Kavita

Institute For Ayurved Studies and Research, Faculty of Ayurved, Kurukshetra

kavitanaik2222@gmail.com7988298059

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026